IDXX - IDEXX Laboratories - Stock Forecast

Healthcare - Sector
Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

IDXX is currently covered by 8 analysts with an average price target of $723.21. This is a potential upside of $71.1 (10.9%) from yesterday's end of day stock price of $652.11.

IDEXX Laboratories's activity chart (see below) currently has 106 price targets and 110 ratings on display. The stock rating distribution of IDXX is 38.71% HOLD and 61.29% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.64% with an average time for these price targets to be met of 246.5 days.

Highest price target for IDXX is $785, Lowest price target is $510, average price target is $587.86.

Most recent stock forecast was given by MARK MASSARO from BTIG on 05-Aug-2025. First documented stock forecast 24-Jun-2014.

Overview

IDEXX Laboratories is a global leader in veterinary diagnostic testing and services, as well as water quality testing solutions. The company primarily serves the companion animal veterinary market, as well as livestock and poultry producers, dairy farmers, and the biomedical research community.

Operations

IDEXX offers a wide range of diagnostic products and services, including point-of-care veterinary diagnostic products, veterinary reference laboratory diagnostic and consulting services, and practice management and diagnostic imaging systems and services for veterinarians. The company also provides health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for the biomedical research community.

In addition to veterinary diagnostic products, IDEXX also offers diagnostic and health-monitoring products for livestock, poultry, and dairy producers. These products include water testing products that test for various microbiological contaminants, as well as point-of-care electrolytes and blood gas analyzers.

During the COVID-19 pandemic, IDEXX also developed an RT-PCR test kit for human COVID-19 testing, called OPTI SARS-CoV-2 RT-PCR test kit.

IDEXX has a broad range of testing capabilities, including in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, as well as SNAP rapid assays test kits. The company also offers veterinary software and services for independent veterinary clinics and corporate groups.

History

The company was founded in 1983 and is headquartered in Westbrook, Maine.

Currently out of the existing stock ratings of IDXX, 12 are a HOLD (38.71%), 19 are a BUY (61.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$785

$134.94 (20.76%)

$500

6 days ago
(05-Aug-2025)

12/13 (92.31%)

$143.06 (22.29%)

155

Hold

$540

$-110.06 (-16.93%)

$510

1 months 9 days ago
(02-Jul-2025)

16/16 (100%)

$-2.71 (-0.50%)

134

Hold

$510

$-140.06 (-21.55%)

$435

6 months 1 days ago
(10-Feb-2025)

9/9 (100%)

$45.09 (9.70%)

87

Hold

$535

$-115.06 (-17.70%)

$565

6 months 7 days ago
(04-Feb-2025)

6/7 (85.71%)

$69.97 (15.05%)

382

Buy

$520

$-130.06 (-20.01%)

$481

6 months 7 days ago
(04-Feb-2025)

10/11 (90.91%)

$54.97 (11.82%)

468

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IDXX (IDEXX Laboratories) average time for price targets to be met?

On average it took 246.5 days on average for the stock forecasts to be realized with a an average price target met ratio 91.64

Which analyst has the current highest performing score on IDXX (IDEXX Laboratories) with a proven track record?

STEVE CHESNEY

Which analyst has the most public recommendations on IDXX (IDEXX Laboratories)?

Steve Chesney has 2 price targets and 2 ratings on IDXX

Which analyst is the currently most bullish on IDXX (IDEXX Laboratories)?

Mark Massaro with highest potential upside - $134.94

Which analyst is the currently most reserved on IDXX (IDEXX Laboratories)?

David Westenberg with lowest potential downside - -$140.06

IDEXX Laboratories in the News

Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market’s attention and produce exceptional returns. However, it isn’t easy to find a great growth stock. By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company’s growth story is over or nearing its...

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?